HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ming-Wei Wang Selected Research

Glucagon-Like Peptides (Enteroglucagon)

12/2020A unique hormonal recognition feature of the human glucagon-like peptide-2 receptor.
10/2016Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.
1/2007A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ming-Wei Wang Research Topics

Disease

28Neoplasms (Cancer)
01/2022 - 08/2005
13Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2007
10Obesity
05/2022 - 01/2009
7Inflammation (Inflammations)
11/2021 - 02/2006
6COVID-19
01/2022 - 11/2020
6Prostatic Neoplasms (Prostate Cancer)
01/2021 - 06/2011
5Neoplasm Metastasis (Metastasis)
01/2014 - 12/2005
5Colorectal Neoplasms (Colorectal Cancer)
09/2012 - 12/2005
4Meningioma (Meningiomas)
01/2020 - 01/2006
4Cognitive Dysfunction
01/2019 - 02/2015
4Insulin Resistance
12/2018 - 08/2008
4Lymphatic Metastasis
11/2017 - 06/2011
3Infections
04/2022 - 01/2012
3Weight Loss (Weight Reduction)
02/2020 - 08/2008
3Hypoxia (Hypoxemia)
12/2019 - 02/2015
3Myocardial Infarction
12/2019 - 02/2009
3Bacterial Infections (Bacterial Infection)
11/2019 - 02/2006
3Leukemia
02/2013 - 11/2004
3Stomach Neoplasms (Stomach Cancer)
01/2012 - 08/2005
3Adenocarcinoma
01/2012 - 01/2006
3Coronary Artery Disease (Coronary Atherosclerosis)
02/2011 - 01/2010
3Body Weight (Weight, Body)
12/2010 - 08/2008
2Pancreatic Neoplasms (Pancreatic Cancer)
06/2022 - 01/2010
2Mental Disorders (Mental Disorder)
01/2022 - 01/2011
2Metabolic Diseases (Metabolic Disease)
12/2021 - 10/2020
2Pain (Aches)
01/2021 - 01/2015
2Hypoglycemia (Reactive Hypoglycemia)
01/2021 - 01/2007
2Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2021 - 02/2008
2Chronic Disease (Chronic Diseases)
01/2020 - 01/2018
2Cardiovascular Diseases (Cardiovascular Disease)
12/2019 - 01/2009
2Osteoporosis
12/2019 - 01/2014
2Neglected Diseases
06/2018 - 09/2011
2Alzheimer Disease (Alzheimer's Disease)
01/2016 - 02/2008
2Neurodegenerative Diseases (Neurodegenerative Disease)
02/2015 - 01/2010
2Parkinson Disease (Parkinson's Disease)
06/2012 - 04/2009
2Metaplasia
06/2009 - 08/2005
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
07/2022
1Non-alcoholic Fatty Liver Disease
05/2022
1Pulmonary Arterial Hypertension
01/2022
1Postmenopausal Osteoporosis
11/2021
1Epididymitis
11/2021
1Orchitis
11/2021
1Necrosis
08/2021
1Vitamin D Deficiency
08/2021

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
01/2021 - 12/2005
15Pharmaceutical PreparationsIBA
05/2022 - 01/2007
13Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2007
9G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
11/2021 - 01/2014
8Glucagon-Like Peptide 1 (GLP 1)IBA
06/2022 - 01/2007
7Glucagon-Like Peptide-1 ReceptorIBA
05/2022 - 08/2008
5Cysteine (L-Cysteine)FDA Link
01/2013 - 12/2005
5Histidine (L-Histidine)FDA Link
01/2013 - 12/2005
4Glucagon Receptors (Glucagon Receptor)IBA
05/2022 - 01/2016
4CytokinesIBA
01/2022 - 01/2015
4Peptide Hormones (Polypeptide Hormones)IBA
10/2021 - 10/2016
4Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2016
4Messenger RNA (mRNA)IBA
01/2017 - 08/2005
4EnzymesIBA
08/2015 - 11/2004
3Formyl Peptide Receptors (Formyl Peptide Receptor)IBA
07/2022 - 11/2004
3Anti-Bacterial Agents (Antibiotics)IBA
11/2021 - 04/2019
3Glucagon-Like Peptides (Enteroglucagon)IBA
12/2020 - 01/2007
3Peptides (Polypeptides)IBA
01/2015 - 06/2010
2LigandsIBA
05/2022 - 02/2020
2Hormones (Hormone)IBA
01/2022 - 01/2007
2SecretinFDA Link
11/2021 - 01/2014
2Therapeutic UsesIBA
11/2021 - 01/2016
2RNA (Ribonucleic Acid)IBA
01/2021 - 12/2019
2ThioredoxinsIBA
01/2021 - 12/2018
2Lysine (L-Lysine)FDA Link
12/2020 - 09/2016
2Glucagon (Glukagon)FDA Link
10/2020 - 01/2017
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
10/2018 - 09/2018
2Sunitinib (Sutent)FDA Link
01/2016 - 01/2014
2Exenatide (Byetta)FDA Link
01/2015 - 01/2007
2CarbohydratesIBA
09/2013 - 01/2009
2Nicotinamide PhosphoribosyltransferaseIBA
02/2011 - 01/2010
2Insulin (Novolin)FDA Link
12/2010 - 08/2008
2LipidsIBA
12/2010 - 01/2009
2Glucagon-Like Peptide-1 Receptor AgonistsIBA
08/2008 - 01/2007
2IntegrinsIBA
01/2007 - 12/2005
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2007 - 12/2005
2Indicators and Reagents (Reagents)IBA
01/2006 - 12/2005
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
07/2022
1beta-Arrestin 1IBA
06/2022
1gastric inhibitory polypeptide receptorIBA
05/2022
1Agrochemicals (Agricultural Chemicals)IBA
04/2022
1Antiviral Agents (Antivirals)IBA
01/2022
1Somatostatin Receptors (Somatostatin Receptor)IBA
01/2022
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
01/2022
1Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
01/2022
1Growth Hormone (Somatotropin)IBA
01/2022
1LipopolysaccharidesIBA
11/2021
1abaloparatideIBA
11/2021
1MelanocortinsIBA
10/2021

Therapy/Procedure

10Therapeutics
05/2022 - 01/2007
3Drug Therapy (Chemotherapy)
01/2019 - 01/2012
3Radiotherapy
11/2017 - 01/2006
2Chinese Traditional Medicine (Traditional Chinese Medicine)
03/2021 - 01/2009
2Transcranial Magnetic Stimulation
01/2019 - 02/2015
2Prostatectomy (Retropubic Prostatectomy)
11/2017 - 06/2011
2Glycemic Control
12/2010 - 08/2008